Genomics

Dataset Information

In vivo screen identifies LXR agonism potentiates sorafenib killing of hepatocellular carcinoma


ABSTRACT: In vivo screen identifies LXR agonism potentiates sorafenib killing of hepatocellular carcinoma

PROVIDER: PRJNA635711 | ENA |

REPOSITORIES: ENA